Ulixertinib
First ERK1/2 inhibitor in clinical trials; overcomes MEK inhibitor resistance. First clinical ERK inhibitor — positioned for MEKi resistance
Description
Scientific Overview: First ERK1/2 inhibitor in clinical trials; overcomes MEK inhibitor resistance. First clinical ERK inhibitor — positioned for MEKi resistance
Mechanism of Action: ERK1/2 Inhibitor
Purity: ≥99% | Molecular Formula: C25H24ClN3O3
For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.
Additional information
| Effect | ERK1/2 Inhibitor |
|---|---|
| Purity | ≥99% |
| Molecular Formula | C25H24ClN3O3 |
| CAS Number | 869357-68-6 |
